These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10576043

  • 21. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F, Lorf T, Schütz E, Christians U, Grupp C, Sattler B, Canelo R, Sewing KF, Armstrong VW, Oellerich M, Ringe B.
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract] [Full Text] [Related]

  • 22. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C, Hollenbeck M, Ivens K, Heering P, Hetzel GR, Grabensee B.
    Transplant Proc; 2001 Dec; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract] [Full Text] [Related]

  • 23. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 Dec; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 24. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Hené RJ, Blom HJ, Demacker PN, Hilbrands LB.
    Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract] [Full Text] [Related]

  • 25. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L, Wang Y, Fu SJ, Cheng XJ.
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract] [Full Text] [Related]

  • 26. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H, Tanabe K, Tokumoto T, Shimuzu T, Ishikawa N, Harano M, Inui M, Manu M, Ito S, Shimmura H, Okuda H, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract] [Full Text] [Related]

  • 27. Drug-induced gingival hyperplasia in transplant recipients.
    Hood KA.
    Prog Transplant; 2002 Mar; 12(1):17-21; quiz 22-3. PubMed ID: 11993065
    [Abstract] [Full Text] [Related]

  • 28. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A, Shaharabani E, Mor E, Lustig S, Bar-Nathan N, Shmueli D, Sobolev V, Dorfman B, Or H, Shapira Z.
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract] [Full Text] [Related]

  • 29. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E.
    Transplantation; 1997 Aug 15; 64(3):436-43. PubMed ID: 9275110
    [Abstract] [Full Text] [Related]

  • 30. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO.
    Transplant Proc; 1996 Apr 15; 28(2):995-7. PubMed ID: 8623494
    [No Abstract] [Full Text] [Related]

  • 31. High QT dispersion in tacrolimus-treated kidney transplant recipients.
    Gerhardt U, Suwelack B, Pawolka A, Hohage H.
    Transplant Proc; 2001 May 15; 33(3):2148-50. PubMed ID: 11377482
    [No Abstract] [Full Text] [Related]

  • 32. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S, Feuring E, Padberg W, Ernst W.
    Transplant Proc; 1998 Jun 15; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract] [Full Text] [Related]

  • 33. Improvement in cyclosporine A associated gingival hyperplasia with azithromycin therapy.
    Boran M, Güneş Z, Doruk F, Gönenç F, Cetin S.
    Transplant Proc; 1996 Aug 15; 28(4):2316. PubMed ID: 8769234
    [No Abstract] [Full Text] [Related]

  • 34. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
    Kohnle M, Zimmermann U, Lütkes P, Albrecht KH, Philipp T, Heemann U.
    Transpl Int; 2000 Aug 15; 13 Suppl 1():S345-8. PubMed ID: 11112029
    [Abstract] [Full Text] [Related]

  • 35. Clinical study of FK 506 in renal transplant recipients.
    Youhua Z, Zhinlian M, Liming W.
    Transplant Proc; 2000 Nov 15; 32(7):1704. PubMed ID: 11119900
    [No Abstract] [Full Text] [Related]

  • 36. Conversion to tacrolimus in hyperlipidemic patients.
    Friemann S, Stopp K, Christ B, Weimer R, Padberg W, Ernst W.
    Transplant Proc; 1999 Nov 15; 31(7A):41S-43S. PubMed ID: 10576042
    [No Abstract] [Full Text] [Related]

  • 37. Use of tacrolimus in renal transplantation.
    van Hooff JP, Christiaans MH.
    Transplant Proc; 1999 Dec 15; 31(8):3298-9. PubMed ID: 10616483
    [Abstract] [Full Text] [Related]

  • 38. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group.
    Transplant Proc; 2005 May 15; 37(4):1874-6. PubMed ID: 15919490
    [Abstract] [Full Text] [Related]

  • 39. Poor oral hygiene enhances gingival overgrowth caused by calcineurin inhibitors.
    Reali L, Zuliani E, Gabutti L, Schönholzer C, Marone C.
    J Clin Pharm Ther; 2009 Jun 15; 34(3):255-60. PubMed ID: 19646074
    [Abstract] [Full Text] [Related]

  • 40. Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.
    Fernando ON, Sweny P, Varghese Z.
    Transplant Proc; 1998 Jun 15; 30(4):1243-4. PubMed ID: 9636505
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.